Alzheimers

Omega-3 Fatty Acids & Souvenaid® May Slow Cognitive Decline in Alzheimer’s Disease (2024 Review)

by

Omega-3 supplements and Souvenaid® show potential in slowing cognitive decline in Alzheimer’s patients, though the evidence remains inconclusive. Highlights: Cognitive Decline Reduction: The CDR scale showed a significant reduction in cognitive decline progression with Omega-3 supplementation (SMD = −0.4127, 95% CI: [−0.5926; −0.2327]). Mixed Cognitive Outcomes: 58% of studies reported positive cognitive effects from Omega-3 …

Read more

ACOT7 Biomarker May Help in Early Diagnosis of Alzheimers Disease (2024 Study)

by

ACOT7 shows promise as a non-invasive serum biomarker for Alzheimer’s disease (AD) with high diagnostic accuracy. Highlights: Increased Expression: ACOT7 levels were significantly elevated in AD patients and animal models compared to controls. Correlation with Cognitive Decline: A strong negative correlation was observed between serum ACOT7 levels and MMSE scores (r = -0.85; p < …

Read more

Occlusion Dysfunction (OD) Causally Linked to Alzheimer’s Disease (2024 Study)

by

Occlusion dysfunction (OD) is causally linked to an increased risk of Alzheimer’s disease (AD), while dentures restoration can mitigate this risk. Highlights: Periodontal disease (PD) and Alzheimer’s do not have a direct causal relationship (P = 0.395). Loose teeth significantly increase the risk of AD progression (P = 0.017, OR = 187.3567). Dentures restoration is …

Read more

Shared Genes & Biological Pathways in Depression & Alzheimer’s Disease (2024 Study)

by

A study found shared brain-specific mechanisms between Alzheimer’s disease (AD) and depression, particularly involving synaptic signaling and immune system pathways in the hippocampus, but no direct genetic overlap. Highlights: Six brain-specific eQTL genes (SRA1, MICA, PCDHA7, PCDHA8, PCDHA10, PCDHA13) are shared between AD and depression. Pathway analysis identified shared biological pathways, including synaptic signaling, myelination, …

Read more

Selegiline Reverses Anxiety & Memory Impairment in Amyloid Beta-Induced Alzheimers Model Rats (2024 Study)

by

The study demonstrated that selegiline (SEL) improves memory performance, reduces anxiety, and modulates oxidative stress in an Alzheimer’s disease (AD) rat model. Highlights: Memory Improvements: SEL administration improved recognition memory, spatial memory, and passive avoidance memory in AD rats. Anxiety Reduction: SEL significantly reduced anxiety-like behavior in AD rats, as evidenced by performance in the …

Read more

Lecanemab for Alzheimers Disease: Reduces Amyloid-Beta Plaques But High ARIA Adverse Events (2024 Review)

by

Lecanemab shows promise in treating Alzheimer’s disease by reducing clinical deterioration and amyloid-beta plaques, but it has significant adverse effects and requires further research for confirmation. Highlights: FDA Approval: The US FDA authorized lecanemab for Alzheimer’s disease treatment in January 2023. Efficacy: Lecanemab significantly reduces clinical deterioration and amyloid-beta plaques in the brain. Adverse Effects: …

Read more

GLP-1 Receptor Agonists & Lower Dementia Risk in Older Adults with Diabetes (2024 Study)

by

TLDR: GLP-1 agonists were found to significantly reduce the risk of dementia in older individuals with type 2 diabetes mellitus (T2DM) compared to DPP-4 inhibitors and sulfonylureas. Highlights: A sequential trial emulation was conducted using data from Swedish national registers from 2010 to 2020, involving 88,381 participants aged 65 or older with T2DM. The incidence …

Read more

Peptide PHDP5 May Reverse Cognitive Impairment in Alzheimers Disease (2024 Research)

by

TLDR: Researchers demonstrated that intranasal administration of the peptide FITC-PHDP5-CPP reverses early cognitive impairment in Alzheimer’s disease (AD) model mice, showing potential as a treatment for AD-associated cognitive decline. Highlights: PHDP5, derived from the pleckstrin homology domain of dynamin 1, inhibits the interaction between dynamin and microtubules, rescuing synaptic dysfunction caused by tau accumulation. The …

Read more

High Salt Intake Linked to Alzheimers Disease & Dementia Risk in Europeans (2024 Study)

by

TLDR: This study provides evidence that high salt intake is causally associated with an increased risk of developing dementia, including Alzheimer’s disease (AD) and undefined dementia. Highlights: Causal Association: High salt intake is significantly associated with an increased risk of any dementia (OR = 1.73) and specifically Alzheimer’s disease (OR = 2.10). Cognitive Performance: Higher …

Read more

CRISPR for Alzheimer’s Disease: Future Treatment via Gene Editing

by

Alzheimer’s disease continues to destroy minds, but new gene editing techniques like CRISPR offer hope for better understanding and treating this devastating illness. Key Facts: Alzheimer’s disease is a complex, poorly understood neurodegenerative disorder affecting over 50 million people worldwide. Gene mutations play a role in early-onset Alzheimer’s, but late-onset Alzheimer’s involves a more complex …

Read more

+ Load more